StockSays

AXP−0.12moodBE−0.72moodBAH−0.06moodARLP±5.7%earnings Oct 26RHI+0.59moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26AXP−0.12moodBE−0.72moodBAH−0.06moodARLP±5.7%earnings Oct 26RHI+0.59moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26

FIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48mood

ALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62mood

HBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65mood

HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27

SGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25mood

CPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32mood

AEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22mood

ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodARE±16.1%earnings Oct 27LEVI−1.00moodABR−0.33moodSNNUF−0.82moodATI±13.6%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodARE±16.1%earnings Oct 27LEVI−1.00moodABR−0.33moodSNNUF−0.82moodATI±13.6%earnings Oct 27

GOVX

← Markets

GOVXGeoVax Labs, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Tue, Oct 27
8:30 AMYahoo
Update - GeoVax Enters Into $1 Million Revolving Loan Agreement
ATLANTA, GA - October 27, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today announced that it has entered into an unsecured...
Mon, Oct 26
5:27 PMYahoo
GeoVax Enters Into $1 Million Revolving Loan Agreement
ATLANTA, GA - October 26, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today announced that it has entered into an unsecured...
Tue, Oct 6
8:37 AMYahoo
GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026
Presentation to Highlight Single-Dose MVA and Continuous Cell-Line MVA Manufacturing Innovations ATLANTA, GA - October 6, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunothe...
Tue, Sep 29
8:37 AMYahoo
GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States
CDC Reports Changing U.S. Transmission Dynamics Underscore Importance of Continued Surveillance, Vaccine Preparedness and Resilient MVA Vaccine Supply ATLANTA, GA - September 29, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stag...
Mon, Sep 21
8:37 AMYahoo
GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models
Study Shows Protection Against Highly Pathogenic Clade I Mpox Virus and Durable CD8+ T-Cell Responses Findings Support GeoVax's Broader Strategy to Expand the Utility of the MVA Vaccine Platform ATLANTA, GA - September 21, 2026 (NEWMEDIAWIRE) - GeoVa...
Wed, Sep 16
8:37 AMYahoo
GeoVax Confirms Bundibugyo Ebola Vaccine Construct
BDBV-Specific Construct Developed Using GeoVax Proprietary Rapid Cloning Technology and Builds on Established Filovirus Vaccine Experience GEO-MVA (Mpox/Smallpox Vaccine) Targeted for Phase 3 Initiation Remains Company Priority ATLANTA, GA - Septembe...
Mon, Sep 14
8:37 AMYahoo
GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial
Independent Evaluation Supports GEO-MVA Pivotal Phase 3 Program Advances GeoVax's Strategy to Expand and Diversify MVA Vaccine Supply ATLANTA, GA - September 14, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology c...
Thu, Sep 10
8:37 AMYahoo
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
ATLANTA, GA - September 10, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high-consequence infectious diseases and solid tumor cancers, today provided an...
Wed, Sep 9
9:00 AMYahoo
GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply
Gavi-funded, ICG-Coordinated Initiative Establishes Long-Term Infrastructure for Timely and Equitable Mpox Vaccine Access During Outbreaks New Stockpile Framework Supports Sustainable Supply and Long-Term Global Preparedness ATLANTA, GA - September 9...
Wed, Aug 26
8:30 AMYahoo
GeoVax Announces a Warrant Inducement Transaction
ATLANTA, GA - August 26, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies, today announced its entry into a warrant inducement agreement with an existing institutio...
Tue, Aug 25
8:37 AMYahoo
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation
Selections of CRO and European Clinical Sites Represent Significant Milestones Toward Initiation of the GEO-MVA Immunobridging Study ATLANTA, GA - August 25, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology compa...
Mon, Aug 24
10:43 AMYahoo
GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak
Emerging Evidence of Potential Protection From Authorized Ebola Zaire Vaccine Against Bundibugyo Virus Provides Rationale for Evaluating GeoVax's MVA-Based Ebola Vaccine Candidates ATLANTA, GA - August 24, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nas...